Published on: 20 May 2021
If psychedelic drugs are introduced in clinical practice, there is a risk that their use will get ahead of the evidence on their safety and efficacy, in much the same way that “medical cannabis” has done, Professor Wayne Hall from UQ’s Centre for Youth Substance Abuse Research has cautioned.